GNTA:ADS (Sponsored)/Genenta Science SpA - Stock Price Quote and Dividend Data
GNTA STOCK PRICE LATEST CLOSE
$3.56
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
ADS (Sponsored)/Genenta Science SpA Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
ADS (Sponsored)/Genenta Science SpA Stock Price Information
52-Week Low/High Stock Price$2.20 - $7.28
Percent Held by Institutions0.00%
Revenue$0
Net Income$-8,912,495
Cash Flow$-6,240,174
EPS0.00%
Market Cap$0
PE Ratio to Industry114%
Debt-Equity Ratio0.00%
Debt-Equity to Industry2.03%
Total Return Last 12 Months7.94%
Total Return Last 3 Years-47.07%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 08, 2025
ADS (Sponsored)/Genenta Science SpA Annual Stock Dividends
No Data available for Payment History.
ADS (Sponsored)/Genenta Science SpA Dividend Payment History
| No dividends retrieved for GNTA |
ADS (Sponsored)/Genenta Science SpA Other Dividend Details
Genenta Science is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors. Co. has developed a biologic platform that involves the ex-vivo gene transfer of a therapeutic candidate into autologous hematopoietic stem or progenitor cells (HSPCs) to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes or macrophages (Tie2 Expressing Monocytes - TEMs). Co.'s technology is designed to turn TEMs into a "Trojan Horse" to counteract cancer progression and to prevent tumor relapse.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Feb. 15, 2025GNTA STOCK PRICE INCREASE: ADS (Sponsored)/Genenta Science SpA on 02-15-2025 increased stock price > 10% from $3.82 to $4.37
Feb. 01, 2025GNTA STOCK PRICE DECREASE: ADS (Sponsored)/Genenta Science SpA on 02-01-2025 decreased stock price > 10% from $4.00 to $3.52
Dec. 31, 2024GNTA STOCK PRICE DECREASE: ADS (Sponsored)/Genenta Science SpA on 12-31-2024 decreased stock price > 10% from $4.88 to $4.30
Nov. 28, 2024GNTA STOCK PRICE INCREASE: ADS (Sponsored)/Genenta Science SpA on 11-28-2024 increased stock price > 10% from $4.78 to $5.38
Nov. 06, 2024GNTA STOCK PRICE DECREASE: ADS (Sponsored)/Genenta Science SpA on 11-06-2024 decreased stock price > 10% from $5.30 to $4.63
Oct. 12, 2024GNTA STOCK PRICE DECREASE: ADS (Sponsored)/Genenta Science SpA on 10-12-2024 decreased stock price > 10% from $6.92 to $5.80
Oct. 11, 2024GNTA STOCK PRICE INCREASE: ADS (Sponsored)/Genenta Science SpA on 10-11-2024 increased stock price > 10% from $5.61 to $6.92
Oct. 10, 2024GNTA STOCK PRICE INCREASE: ADS (Sponsored)/Genenta Science SpA on 10-10-2024 increased stock price > 10% from $5.00 to $5.61
Sep. 20, 2024GNTA STOCK PRICE INCREASE: ADS (Sponsored)/Genenta Science SpA on 09-20-2024 increased stock price > 10% from $3.30 to $3.85
Sep. 07, 2024GNTA STOCK PRICE DECREASE: ADS (Sponsored)/Genenta Science SpA on 09-07-2024 decreased stock price > 10% from $4.77 to $4.14
Apr. 09, 2025TCBPY STOCK PRICE DECREASE: TC BioPharm (Holdings) plc on 04-09-2025 decreased stock price > 10% from $0.40 to $0.27
Apr. 09, 2025MAZE STOCK PRICE DECREASE: Maze Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $8.92 to $7.57
Apr. 09, 2025KANT STOCK PRICE DECREASE: Kineta Inc on 04-09-2025 decreased stock price > 10% from $0.35 to $0.30
Apr. 09, 2025ORKA STOCK PRICE DECREASE: Oruka Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $7.62 to $6.78
Apr. 09, 2025XCUR STOCK PRICE DECREASE: Com Par $0.0001/Exicure Inc on 04-09-2025 decreased stock price > 10% from $12.80 to $11.39
Apr. 09, 2025BIVI STOCK PRICE DECREASE: Cl A Par $0.0001/BioVie Inc on 04-09-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 09, 2025ARTV STOCK PRICE DECREASE: Artiva Biotherapeutics Inc on 04-09-2025 decreased stock price > 10% from $3.31 to $1.92
Apr. 09, 2025ENTO STOCK PRICE DECREASE: Com Par $0.0001 (New)/Entero Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.49 to $0.42
Apr. 09, 2025APDN STOCK PRICE DECREASE: Com Par $0.001 (New)/Applied DNA Sciences Inc on 04-09-2025 decreased stock price > 10% from $1.30 to $1.13
Apr. 09, 2025RKVTF STOCK PRICE DECREASE: Rakovina Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $0.06 to $0.05
